Erste Asset Management GmbH Buys Shares of 669,702 MeiraGTx Holdings plc (NASDAQ:MGTX)

Erste Asset Management GmbH bought a new position in MeiraGTx Holdings plc (NASDAQ:MGTX) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 669,702 shares of the company’s stock, valued at approximately $2,795,000. Erste Asset Management GmbH owned 1.03% of MeiraGTx as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Knoll Capital Management LLC purchased a new stake in MeiraGTx in the 3rd quarter worth about $5,212,000. BNP Paribas Financial Markets increased its holdings in shares of MeiraGTx by 142.5% in the 3rd quarter. BNP Paribas Financial Markets now owns 9,319 shares of the company’s stock valued at $39,000 after purchasing an additional 5,476 shares during the period. Royce & Associates LP lifted its position in shares of MeiraGTx by 5.3% in the third quarter. Royce & Associates LP now owns 795,392 shares of the company’s stock worth $3,317,000 after purchasing an additional 40,000 shares in the last quarter. Privium Fund Management B.V. boosted its holdings in shares of MeiraGTx by 4.9% during the third quarter. Privium Fund Management B.V. now owns 213,960 shares of the company’s stock worth $892,000 after purchasing an additional 10,000 shares during the period. Finally, China Universal Asset Management Co. Ltd. grew its position in MeiraGTx by 97.0% during the third quarter. China Universal Asset Management Co. Ltd. now owns 14,886 shares of the company’s stock valued at $62,000 after purchasing an additional 7,330 shares in the last quarter. Institutional investors and hedge funds own 67.48% of the company’s stock.

Analyst Ratings Changes

A number of research firms have issued reports on MGTX. Chardan Capital reiterated a “buy” rating and issued a $36.00 target price on shares of MeiraGTx in a research report on Monday, November 18th. Royal Bank of Canada lifted their price objective on MeiraGTx from $9.00 to $11.00 and gave the company an “outperform” rating in a research report on Thursday, November 14th.

MeiraGTx Price Performance

Shares of MGTX opened at $6.64 on Tuesday. The company has a debt-to-equity ratio of 0.86, a quick ratio of 2.34 and a current ratio of 2.34. The firm has a market cap of $518.92 million, a PE ratio of -5.60 and a beta of 1.24. The firm’s 50 day moving average price is $5.54 and its 200 day moving average price is $4.87. MeiraGTx Holdings plc has a twelve month low of $3.85 and a twelve month high of $7.60.

MeiraGTx Company Profile

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.